Publications by authors named "Daniel Karp"

Claim this Profile
T
The Importance of Landscape Composition for Pest Control and Crop Yield: A Global Quantitative Synthesis.
Katja Poveda, Daniel S Karp, Rebecca Chaplin-Kramer, Mary Centrella, Tim Luttermoser

Ecol Lett· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers.
Steven H Lin, Vivek Subbiah, Shinya Neri, Evan N Cohen, Ziyi Li, Daniel Karp

Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One landscape does not fit all: Diverse arthropod responses to land use.
Mia K Lippey, Jay A Rosenheim, Daniel Paredes, Daniel S Karp, Sara E Emery

Ecol Appl· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, Ecaterina E Dumbrava, David S Hong, Daniel D Karp

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, Amadeo B Biter, Joann Lim, Daniel D Karp

J Immunother Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study.
Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, Jing Gong, Selma Sulovic

Invest New Drugs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.
Jibran Ahmed, Bettzy Stephen, Muhammad R Khawaja, Yali Yang, Israa Salih, Daniel D Karp

Gynecol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.
Jibran Ahmed, Filip Janku, Daniel D Karp, Sarina A Piha-Paul, Apostolia M Tsimberidou

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, Hassan Ahmed Momin, Bulent Yilmaz, Daniel D Karp

Cancer Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning From Mistakes: Navigating Medical Errors in Oncology From Prevention to Management.
Daniel D Karp, Jessica A Osburn, Mohamed A Gouda

J Immunother Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types.
Vijaykumar R Holla, Michael P Kahle, Sun-Hee Kim, Arash Ronaghy, Richard K Yang, Daniel D Karp

JCO Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies.
Joe Y Chang, Xinyan Xu, Girish S Shroff, Nathan I Comeaux, Wei Li, Daniel D Karp

J Immunother Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of agriculture and nature reserves on avian behavior in northwestern Costa Rica.
Alison Ke, Rahel Sollmann, Luke Frishkoff, Alejandra Echeverri, Jim Zook, Daniel S Karp

Conserv Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations.
Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, Ying Yuan, Daniel D Karp

NPJ Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer.
Chad Tang, Genevieve P Hartley, Coline Couillault, Ying Yuan, Heather Lin, Daniel D Karp

BMJ Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging satellite observations to reveal ecological drivers of pest densities across landscapes.
Sara E Emery, Jay A Rosenheim, Rebecca Chaplin-Kramer, Richard Sharp, Daniel S Karp

Sci Total Environ· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp

Oncologist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint environmental and social benefits from diversified agriculture.
Laura Vang Rasmussen, Ingo Grass, Zia Mehrabi, Olivia M Smith, Rachel Bezner-Kerr, Daniel S Karp

Science· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
Anne Knisely, Jibran Ahmed, Bettzy Stephen, Sarina A Piha-Paul, Daniel Karp

Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Niamh Coleman, Bettzy Stephen, Siqing Fu, Daniel Karp, Vivek Subbiah

Cancer Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous submission of seven CTSA proposals: UM1, K12, R25, T32-predoctoral, T32-postdoctoral, and RC2: strategies, evaluation, and lessons learned.
Carolina Lema, Kwai Wa Cheng, Delanderia M Anderson, Charles C Miller, Daniel D Karp

J Clin Transl Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum temperatures determine the habitat affiliations of North American mammals.
Mahdieh Tourani, Rahel Sollmann, Roland Kays, Jorge Ahumada, Eric Fegraus, Daniel S Karp

Proc Natl Acad Sci U S A· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agriculture and hot temperatures interactively erode the nest success of habitat generalist birds across the United States.
Katherine S Lauck, Alison Ke, Elissa M Olimpi, Daniel Paredes, Kees Hood, Daniel S Karp

Science· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.
Sarina A Piha-Paul, Chieh Tseng, Hai T Tran, Meng Gao, Daniel D Karp

Cancer Chemother Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance of HER2 Expression and/or Amplification on Repeat Testing.
Timothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, Daniel D Karp, Jaffer A Ajani

Mol Cancer Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis